DIROXIMEL FUMARATE

Trials studying DIROXIMEL FUMARATE

• —A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babiesactive not recruitingn=1,178
• —A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosisrecruitingn=800
• phase3A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)not yet recruitingn=185
• phase3A Study of Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS)completedn=136
• —A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)active not recruitingn=10,500
• —Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)recruitingn=908
• —Study of Diroximel Fumarate in the Real-World Settingterminatedn=75